Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ziobro, Julie
ARGUS, NCT04462770 / 2021-003425-30: A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome	Recruiting	2	100	Europe, Canada, US, RoW	EPX-100 (clemizole HCl), Placebo	Epygenix, Harmony Biosciences, LLC	Dravet Syndrome	04/26	05/26
Stosic, Maya
ARGUS, NCT04462770 / 2021-003425-30: A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome	Recruiting	2	100	Europe, Canada, US, RoW	EPX-100 (clemizole HCl), Placebo	Epygenix, Harmony Biosciences, LLC	Dravet Syndrome	04/26	05/26
Nordhaus, Brittany
ARGUS, NCT04462770 / 2021-003425-30: A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome	Recruiting	2	100	Europe, Canada, US, RoW	EPX-100 (clemizole HCl), Placebo	Epygenix, Harmony Biosciences, LLC	Dravet Syndrome	04/26	05/26